Results 11 to 20 of about 19,681 (244)

Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case–control study [PDF]

Diabetology & Metabolic Syndrome
Background Exocrine pancreatic insufficiency (EPI) can be associated with all types of diabetes. Pancreatic enzyme replacement therapy (PERT) has short and long-term benefits in subjects with EPI, but its effects on diabetes control are uncertain.
Laure Alexandre-Heymann, Fetta Yaker, Pierre Bel Lassen, Danièle Dubois-Laforgue, Etienne Larger   +4 more
doaj   +2 more sources

Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study [PDF]

Nutrients, 2022
Daniel Faurholt-Jepsen, Terese L Katzenstein, Christian Mølgaard   +2 more
exaly   +2 more sources

Survey of Pancreatic Enzyme Replacement Therapy Dosing Experiences in Adults with Exocrine Pancreatic Insufficiency [PDF]

Healthcare (Switzerland), 2023
Dana Lewis, Arsalan Shahid, Lewis Dana M   +2 more
exaly   +2 more sources

Recent advances in pancreatic enzyme replacement and insulin therapy in patients with pancreatic insufficiency

Suizo, 2007
膵内外分泌不全の病態を正しく理解し，十分な食事療法（膵炎食ではない）に加え，膵性脂肪便をはじめとする消化吸収不良を膵酵素製剤の補充によって治療する．更に，膵性糖尿病の血糖コントロールを自己血糖測定下に超速効型インスリン，持効型（中間型）インスリンを組み合わせることによって患者のQuality of life及び予後は著しく改善してきた．しかし，新しいインスリン製剤によってより良い血糖コントロールが，糖尿病固有の最小血管障害（腎症）の進行をどの程度抑制するかについての臨床データはまだ存在していない．
Teruo Nakamura, Miyuki Yanagimachi, Yusuke Tando   +2 more
exaly   +3 more sources

Hospitalization rates among patients with cystic fibrosis using pancreatic enzyme replacement therapy [PDF]

Chronic Respiratory Disease, 2020
Bruce Trapnell
exaly   +2 more sources

Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer [PDF]

Cochrane Database Syst Rev, 2018
Nofal Y, Abu Dail Y, Assaf Y, Abo Samra H, Abbas F, Hamzeh A, Alhaj Hasan N.   +6 more
europepmc   +3 more sources

Current and Future Therapeutic Approaches of Exocrine Pancreatic Insufficiency in Children with Cystic Fibrosis in the Era of Personalized Medicine

Pharmaceutics, 2023
This review presents current updates of pancreatic enzyme replacement therapy in children with cystic fibrosis based on literature published in the last decade and some special considerations regarding pancreatic enzyme replacement therapy in the era of ...
Mirela-Elena Ritivoiu, Cristina Manuela Drăgoi, Dumitru Matei, Iustina Violeta Stan, Alina Crenguţa Nicolae, Mihai Craiu, Ion-Bogdan Dumitrescu, Alina Angelica Ciolpan   +7 more
doaj   +1 more source

Innovations in Pancreatic Enzyme Replacement Therapy for Enterally Fed Patients With Pancreatic Cancer. [PDF]

Gastroenterol Nurs
Christie W, Spears CO, Paul K.
europepmc   +3 more sources

AGA-PancreasFest Joint Symposium on Exocrine Pancreatic Insufficiency

Gastro Hep Advances, 2023
Exocrine pancreatic insufficiency (EPI) is a clinically defined syndrome based on the physician’s assessment of a patient’s maldigestion. However, current clinical definitions are inadequate in determining (1) the threshold of reduced pancreatic ...
David C. Whitcomb, Sinead N. Duggan, Robert Martindale, Mark Lowe, Virginia A. Stallings, Darwin Conwell, Jodie A. Barkin, Georgios I. Papachristou, Sohail Z. Husain, Christopher E. Forsmark, Vivek Kaul   +10 more
doaj   +1 more source

Pancreatic Enzyme Replacement Therapy in hyperglycemic Male Rats

Kufa Journal for Veterinary Medical Sciences, 2020
The study was designed to evaluated exocrine pancreatic enzyme replacement therapy in hyperglycemic male rats induced by alloxan. A total of forty five adult male rats were use in this study, hyperglycemia was induce in thirty rats by single ...
Muhammad Ali Hameed Jalil, Nabeel M. N. Al-Sharafi   +1 more
doaj   +1 more source